Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study.

6533b830fe1ef96bd129722c

RESEARCH PRODUCT

Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study.

Didier Carrié Jean-bernard Ruidavets Marion Pouche Luc Lorgis Nicolas Danchin Hervé Douard Tabassome Simon Philippe Brunel Vincent Bataille Jean Ferrières Marie-christine Iliou

subject

Male MESH: Chi-Square Distribution medicine.medical_treatment MESH : Acute Coronary Syndrome Myocardial Infarction MESH : Aged MESH : Prospective Studies Cardiac rehabilitation MESH: Risk Assessment 0302 clinical medicine Myocardial infarction Prospective Studies Referral and Consultation MESH: Treatment Outcome Rehabilitation MESH: Middle Aged General Medicine MESH: Follow-Up Studies 3. Good health MESH: Myocardial Infarction MESH : Patient Discharge Cardiology and Cardiovascular Medicine medicine.medical_specialty Acute myocardial infarction Mortalité Risk Assessment 03 medical and health sciences [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system Humans MESH : Middle Aged Acute Coronary Syndrome MESH: Kaplan-Meier Estimate Aged Chi-Square Distribution MESH: Humans MESH : Chi-Square Distribution Proportional hazards model MESH: Patient Discharge MESH : Humans Patient survival MESH : Follow-Up Studies medicine.disease MESH : Proportional Hazards Models MESH: Acute Coronary Syndrome ST-segment elevation myocardial infarction MESH: Female Time Factors MESH: Registries Kaplan-Meier Estimate 030204 cardiovascular system & hematology MESH : Referral and Consultation MESH: Proportional Hazards Models Older patients Risk Factors MESH: Risk Factors MESH : Female 030212 general & internal medicine Registries MESH : Risk Assessment MESH: Aged Ejection fraction Non–ST-segment elevation myocardial infarction Middle Aged [ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system MESH : Risk Factors Patient Discharge Treatment Outcome Female France MESH : Time Factors MESH : Male MESH : Treatment Outcome MESH: Multivariate Analysis MESH : Kaplan-Meier Estimate MESH: Referral and Consultation Internal medicine Infarctus du myocarde sans sus-décalage du segment ST medicine In patient cardiovascular diseases Medical prescription Mortality Réadaptation cardiaque MESH : France Proportional Hazards Models business.industry Infarctus du myocarde avec sus-décalage du segment ST MESH: Time Factors MESH : Multivariate Analysis MESH: Male MESH: Prospective Studies Surgery MESH: France Infarctus du myocarde aigu Multivariate Analysis MESH : Myocardial Infarction business MESH : Registries Follow-Up Studies

description

IF 2.271; International audience; Background. - Clinical studies have shown a beneficial effect of cardiac rehabilitation (CR) on mortality.Objective. - To study the effect of CR prescription at discharge on 5-year mortality in patients with acute myocardial infarction (AMI).Methods. - Participants, from the 2005 French FAST-MI hospital registry, were 2894 survivors at discharge, divided according to AMI type: ST-segment elevation myocardial infarction (STEMI; n=1523) and non-STEMI (NSTEMI; n=1371). The effect of CR prescription on mortality was analysed using a Cox proportional hazards model.Results. - At discharge, 22.1% of patients had a CR prescription. Patients referred to CR were younger (62.4 vs. 67.5 years), were more frequently men and more had presented with STEMI (67.8% vs. 48.3%) than non-referred patients. Ninety-four (14.7%) deaths occurred among patients referred to CR and 585 (25.9%) among non-referred patients (P= 60 years) and AMI type showed that the inverse association was stronger in men (HR 0.64, 95% CI 0.48-0.87) than in women (HR 0.95, 95% CI 0.64-1.39), in younger (HR 0.34, 95% CI 0.15-0.77) than in older patients (HR 0.84, 95% CI 0.65-1.07) and in NSTEMI (HR 0.63, 95% CI 0.46-0.88) than in STEMI (HR 0.99, 95% CI 0.69-1.40).Conclusion. - After hospitalization for AMI, referral to CR remains a significant predictor of improved patient survival; some subgroups seem to gain greater benefit. (C) 2015 Elsevier Masson SAS. All rights reserved.

year	journal	country	edition	language
2016-03-01

10.1016/j.acvd.2015.09.009 https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01441551